StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Magenta Therapeutics (MGTA) to Resume Trading at 8:30 a.m.
July 21, 2021 8:08 AM
Magenta Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
FDA's Clinical Hold Doesn't Affect Magenta Therapeutics' (MGTA) MGTA-117 Prospects - Analyst
July 21, 2021 10:51 AM
Magenta Therapeutics (MGTA) receives clinical hold letter from FDA related to IND to initiate Phase 1/2 clinical trial of MGTA-117 in patients with AML and MDS
July 21, 2021 8:01 AM
Magenta Therapeutics Announces Update on U.S. FDA Investigational New Drug Application for MGTA-117 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
July 21, 2021 8:00 AM
Magenta Therapeutics (MGTA) Halted, News Pending
July 21, 2021 7:55 AM
